UNSPSC 85612509: Supplement left hepatic duct with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left hepatic duct with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FU637Z

UNSPSC 85612509 Supplement left hepatic duct with autologous tissue substitute, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity. The recent opportunities posted under this code — independent medical evaluation services, pharmacy benefit management, occupational health surveillance, surgical benefit carve-outs, emergency medical services for detained youth, and temporary health professional staffing — bear no connection to hepatic surgical procedures or tissue-engineering interventions. The code appears to describe a specific surgical technique within a medical-device or procedural taxonomy that state and local jurisdictions do not procure as standalone line items through traditional RFP, RFQ, IFB, or ITT processes.

State and local governments purchase medical services and staffing through broader procurement vehicles targeting insurance administration, occupational health programs, emergency care networks, and temporary clinical staffing. They do not solicit individual surgical interventions by UNSPSC commodity code. Unless your firm manufactures or supplies tissue substitutes, surgical instruments, or implantable devices at scale to state health systems or hospital networks, this code does not represent a viable procurement pathway.